PDF herunterladen
Neuropediatrics 2013; 44(05): 265-267
DOI: 10.1055/s-0033-1333873
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Association of Acute Cerebellar Ataxia and Human Papilloma Virus Vaccination: A Case Report

Chihiro Yonee
1   Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Kagoshima, Japan
,
Mitsuo Toyoshima
1   Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Kagoshima, Japan
,
Yoshihiro Maegaki
2   Division of Child Neurology, Institute of Neurological Science, Tottori University Faculty of Medicine, Yonago City, Tottori, Japan
,
Yuichi Kodama
1   Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Kagoshima, Japan
,
Hiroshi Hayami
3   Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Kagoshima, Japan
,
Yukitoshi Takahashi
4   Department of Pediatrics, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka City, Shizuoka, Japan
,
Susumu Kusunoki
5   Department of Neurology, School of Medicine, Kinki University, Sayama City, Osaka, Japan
,
Ayumi Uchibori
6   Department of Neurology, School of Medicine, Kyorin University, Mitaka City, Tokyo, Japan
,
Atsuro Chiba
6   Department of Neurology, School of Medicine, Kyorin University, Mitaka City, Tokyo, Japan
,
Yoshifumi Kawano
1   Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Kagoshima, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

22. August 2012

02. Januar 2013

Publikationsdatum:
01. Februar 2013 (online)

    Lizenzen und Reprints

Abstract

Introduction We report the case of a patient who developed symptoms of acute cerebellar ataxia (ACA) after administration of the human papilloma virus (HPV)-16/18 vaccine.

Patient and Method This patient developed symptoms of ACA, including nausea, vertigo, severe limb and truncal ataxia, and bilateral spontaneous continuous horizontal nystagmus with irregular rhythm, 12 days after administration of the HPV-16/18 AS04-adjuvanted cervical cancer vaccine. After this, the patient received methylprednisolone pulse and intravenous immunoglobulin (IVIG) therapies as well as immunoadsorption plasmapheresis.

Results Severe ACA symptoms did not improve after methylprednisolone pulse and IVIG therapies, but the patient recovered completely after immunoadsorption plasmapheresis.

Conclusion This temporal association strongly suggests that ACA was induced by the vaccination.

Keywords

acute cerebellar ataxia - human papilloma virus vaccination - immunoadsorption plasmapheresis therapy
 

  • References

  • 1 Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol 1994; 35 (6) 673-679
    CrossrefPubMedGoogle Scholar
  • 2 Sunaga Y, Hikima A, Ostuka T, Morikawa A. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatr Neurol 1995; 13 (4) 340-342
    CrossrefPubMedGoogle Scholar
  • 3 Deisenhammer F, Pohl P, Bösch S, Schmidauer C. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurol Scand 1994; 89 (6) 462-463
    PubMedGoogle Scholar
  • 4 Souayah N, Michas-Martin PA, Nasar A , et al. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine 2011; 29 (5) 886-889
    CrossrefPubMedGoogle Scholar
  • 5 Nussinovitch M, Prais D, Volovitz B, Shapiro R, Amir J. Post-infectious acute cerebellar ataxia in children. Clin Pediatr (Phila) 2003; 42 (7) 581-584
    CrossrefPubMedGoogle Scholar
  • 6 Harper DM, Franco EL, Wheeler C , et al; GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364 (9447) 1757-1765
    Google Scholar
  • 7 Kanduc D. Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J Exp Ther Oncol 2009; 8 (1) 65-76
    PubMedGoogle Scholar
  • 8 Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 (Suppl. 01) S16-S24
    Google Scholar
  • 9 Ribassin-Majed L, Lounes R, Clémençon S. Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies. PLoS ONE 2012; 7 (3) e32251
    CrossrefPubMedGoogle Scholar
  • 10 Marn Pernat A, Buturović-Ponikvar J, Svigelj V, Ponikvar R. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption. Ther Apher Dial 2009; 13 (4) 310-313
    CrossrefPubMedGoogle Scholar